Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...

Ozempic, a brand name for semaglutide, has gained significant attention in the medical community and among patients for its ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk has an opportunity to expand indications on its weight loss drugs. Check out on what could be next for NVO stock ...

NVO stock declines after a recent obesity study setback and intense competition from market rivals but offers long-term ...

The task ahead of Vertex now is to migrate patients already on Trikafta to the new drug. That is supported by data from the ...

It’s been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling.

The investigational therapy works to impede the expression of genes that cause the body to store fat as a potential treatment for obesity.

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Shares of Novo Nordisk (CSE: NOVOb) continued their upward momentum on Tuesday, rising over 5%, following gains on Monday.